Hypercoagulable states.
Yardumian A, Machin SJ.
Int Anesthesiol Clin. 1985 Summer;23(2):141-55. doi: 10.1097/00004311-198523020-00012.
Oral contraceptives: a reassessment.
Derman R.
Obstet Gynecol Surv. 1989 Sep;44(9):662-8. doi: 10.1097/00006254-198909000-00005.
Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations.
Velásquez M, Rojas M, Abrahams VM, Escudero C, Cadavid ÁP.
Front Physiol. 2018 Dec 21;9:1840. doi: 10.3389/fphys.2018.01840. eCollection 2018.
Modern oral contraceptives and cardiovascular disease.
Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.
Am J Obstet Gynecol. 1997 Sep;177(3):707-15. doi: 10.1016/s0002-9378(97)70168-6.
Clinical pharmacology of the steroidal oral contraceptives.
Durand JL, Bressler R.
Adv Intern Med. 1979;24:97-126.
[Combined oral contraceptives].
Baulieu E, Ferin J, De Gennes JL, Netter A, Palmer R, Rozenbaum H.
Fertil Orthog. 1973 Jan;5(1):205-12.
Cardiovascular risks: perception versus reality.
Mishell DR Jr.
Contraception. 1999 Jan;59(1 Suppl):21S-24S. doi: 10.1016/s0010-7824(98)00133-4.
Thrombotic disorders associated with pregnancy and the pill.
Tooke JE, McNicol GP.
Clin Haematol. 1981 Jun;10(2):613-30.
Effects of oral contraceptives on blood coagulation. A review.
Beller FK, Ebert C.
Obstet Gynecol Surv. 1985 Jul;40(7):425-36. doi: 10.1097/00006254-198507000-00003.
[Chronic illness and contraception].
Saarikoski S.
Duodecim. 1987;103(9):593-7.
